Latest Molecular Diagnostics News

Vertex's Cystic Fibrosis Drug Kalydeco Given Green Light By EU's Scientific Advisory PanelVertex's cystic fibrosis product Kalydeco is one of five new molecular entities given a positive opinion by Europe's Committee for Medicinal Products for Human Use on May 25, which also included Almirall's novel COPD therapy aclidinium and Novo Nordi...

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic UseAdvanced Biological Laboratories (ABL) announced today that DeepChek® and ViroScore® Suite clinical genotyping solutions are now CE-IVD (In Vitro Diagnostics) approved for commercial use in Europe and other countries that recognise CE certification. This approval is further validating the use of our next generation sequencing (NGS) downstream an...

Oxidation reaction is first-ever with well-defined alignment, spinAn important chemical species, molecular oxygen is linear, has an anisotropic shape, and spins from two unpaired electrons. However, until now, we didn’t know how these properties influenced important oxidation reactions. Researchers in Japan h...

The Pancreatic Cancer Research & Education Act (S.362) Reaches 50 Senate Co-Sponsors and Majority of Senate Help CommitteeMANHATTAN BEACH, Calif., May 25, 2012 /PRNewswire/ -- The Pancreatic Cancer Action Network is calling on Congress to pass the Pancreatic Cancer Research & Education Act (S. 362/H.R. 733). The bill reached a critical point today with Senator Johnny Isakson (R-GA) signing on as the 50th co-sponsor of the lifesaving legislation and with his support, the bill also has majority of the Senate...

True Diagnostics wins CE mark approval for TrueDX Platform,TSH testTrue Diagnostics has obtained CE mark approval for its TrueDX Platform and thyroid stimulating hormone (TSH) test.

Clear Criteria and Formal Selection Committees Make Choosing Diagnostics Partners Less TrickyBy David Richardson, Research Team Leader Choosing a partner for the development of a companion diagnostic can have far reaching consequences. Making the right partner connection can prove lucrative. Unfortunately for decision makers, selecting the w...

MDxHealth: Annual and Extraordinary General Shareholders’ MeetingRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Annual and Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Annual General Meeting, including th...

Safeguard Scientifics Appoints Dr. Keith B. Jarrett to Board of DirectorsSafeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and

11 Scientists Funded to Move Arthritis Research ForwardEleven cutting-edge scientists researching arthritis have been awarded grants totaling $810,000 by the Arthritis National Research Foundation. Moving arthritis research forward with new, innovative ideas. Long Beach, CA (PRWEB) May 25, 2012 Eleven scientists researching arthritis were recently awarded grants totaling $810,000 by the Arthritis National Research Foundation. With 50 million America...

Cepheid to launch Xpert CT/NG and Xpert CT in Europe for rapid detection, differentiation of chlamydia & gonorrhoeaeCepheid, a leading molecular diagnostics company, has received CE marking for Xpert CT/NG and Xpert CT. The company announced that the shipment is expected to begin immediately.

Scientists discover how microglia detect the site of injuryLike emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. Scientists at the European Molecular Biol...

Study Validating miRview mets2 Published in The Oncologist PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 05/25/12 -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that data from studies of miRview® mets² in patients with Cancer of Unknown and Uncertain Primary ("CUP") were published online in The Oncologist in an article titled, "A second generation microR...

Picture release: More than meets the eye(European Molecular Biology Laboratory) Images of the cell's transport pods, produced at EMBL Heidelberg, revealed a molecular version of the robots from Transformers, published online today in Science.

Researchers Detect Predictive Biomarkers Of The Fertilizing Capacity Of Sperm DonorsThe study represents a breakthrough in understanding the causes of unexplained infertility The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, normal quality semen does not guarantee a...

When nanoparticles become “artificial atoms”The contention of a major but controversial new theory to explain nanocrystal growth is that nanoparticles can act as “artificial atoms,” forming molecular-type building blocks that can assemble into complex structures. The conclusion is base...

Attractive and repulsive Fermi polarons in two dimensionsThe dynamics of a single impurity in an environment is a fundamental problem in many-body physics. In the solid state, a well known case is an impurity coupled to a bosonic bath (such as lattice vibrations); the impurity and its accompanying lattice...

Metastability and coherence of repulsive polarons in a strongly interacting Fermi mixtureUltracold Fermi gases with tunable interactions provide a test bed for exploring the many-body physics of strongly interacting quantum systems. Over the past decade, experiments have investigated many intriguing phenomena, and precise measurements of...

India steps up efforts to battle rising tide of diabetesIndia is combining a string of initiatives, ranging from an ongoing screening programme which now includes a pilot covering school children, research studies and support for the development of cut-price diagnostics, to tackle the growing incidence of...

Pacific Dental to buy LED Medical VELscope Vx systemsPacific Dental Services has entered into a three year agreement to purchase LED Medical Diagnostics' 400 VELscope Vx systems.

AspenBio Appoints Diagnostics Industry Veteran Don Hurd as Senior Vice President and Chief Commercial OfficerAspenBio Pharma, Inc. (Nasdaq: APPY), today announced that Don Hurd has been appointed to the new position of Senior Vice President and Chief Commercial Officer, effective May 23, 2012. Mr. Hurd brings to AspenBio Pharma over 30 years of experience in the medical diagnostic and device industry with a diverse background in sales, marketing, strategic planni...

Exciting New Research Results Reported at the Recent European Society of Cardiology Heart Failure Congress in BelgradeCritical Diagnostics, makers of the Presage® ST2 Assay, announced today that ST2, an emerging heart disease biomarker, remains at the forefront in cardiology clinical research. At the recently concluded European Heart Failure Congress results describing the clinical utility of ST2 in patients with heart failure were reported in six different summaries....

Transgenomic Acquires Clinical Sample Biorepository from Gene LogicTransgenomic, Inc. (OTCBB: TBIO) today announced it has entered into an agreement with Gene Logic, Inc., an Ocimum Biosolutions Company, to acquire its biorepository assets for $250,000 in cash. The biorepository contains thousands of human biological samples that can be used to validate diagnostic assays developed by Transgenomic. Transgenomic will use th...

Thermo Fisher Scientific Declares Quarterly DividendThermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.13 per share. The dividend will be paid on July 16, 2012, to shareholders of record as of June 15, 2012. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE...

Myriad and Intermountain Healthcare to Collaborate on Molecular DiagnosticsMyriad Genetics, Inc., a molecular diagnostics company, and Intermountain Healthcare, a nonprofit organization that provides affordable medical care, have signed...

Locating ground zero: How the brain's emergency workers find the disaster areaLike emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. Scientists at the European Molecular Biol...

0 1 2 3 4 ›»

buy Molecular Diagnostics market research data and corporate reports now Advertisement